AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsInformation ScienceHealth Care
Leukemia, Myeloid, AcuteLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemiaCytarabineFusion Proteins, bcr-ablBlast CrisisGene Expression Regulation, LeukemicAcute Diseasefms-Like Tyrosine Kinase 3Remission InductionBenzamidesDaunorubicinLeukemia, Lymphocytic, Chronic, B-CellMyelodysplastic SyndromesLeukemia, LymphoidK562 CellsLeukemia, ExperimentalPiperazinesPyrimidinesPrecursor Cell Lymphoblastic Leukemia-LymphomaHL-60 CellsKaryotypingCore Binding Factor Alpha 2 SubunitBone MarrowLeukemia, Myeloid, Chronic-PhaseLeukemia, Myelomonocytic, AcuteCytogenetic AnalysisLeukemia, Monocytic, AcuteAntineoplastic AgentsPhiladelphia ChromosomeIdarubicinChromosomes, Human, Pair 21Translocation, GeneticMyeloid-Lymphoid Leukemia ProteinBone Marrow TransplantationGenes, ablPrognosisSialic Acid Binding Ig-like Lectin 3Oncogene Proteins, FusionAntineoplastic Combined Chemotherapy ProtocolsLeukemia Virus, MurineChromosome AberrationsChromosomes, Human, Pair 8CytogeneticsTreatment OutcomeNeoplastic Stem CellsChromosomes, Human, 21-22 and YTumor Cells, CulturedHematopoietic Stem CellsTransplantation, HomologousNeoplasm ProteinsRecurrenceLeukemia, Myeloid, Accelerated PhaseDrug Resistance, NeoplasmLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeMitoxantroneNeoplasm, ResidualSurvival AnalysisLeukemia, Radiation-InducedMutationHematopoietic Stem Cell TransplantationThioguanineDisease-Free SurvivalSarcoma, MyeloidLeukemia, T-CellApoptosisAntigens, CD34Protein Kinase InhibitorsTandem Repeat SequencesSurvival RateMyeloproliferative DisordersImmunophenotypingProto-Oncogene Proteins c-bcrFlow CytometryProto-OncogenesProto-Oncogene ProteinsLeukemic InfiltrationArabinonucleosidesCell DifferentiationGranulocytesLeukemia, Megakaryoblastic, AcuteMoloney murine leukemia virusGene RearrangementNeoplasms, Second PrimaryCore Binding FactorsCell Line, TumorLeukemia, B-CellEtoposideRNA, NeoplasmLeukemia, Hairy CellAnemia, Refractory, with Excess of BlastsU937 CellsBase SequenceCell Transformation, NeoplasticBone Marrow CellsBusulfanLeukemia L1210Chromosomes, Human, Pair 11Vidarabine
Promyelocytic leukemiaNeoplasmsMyelocyticMyelomonocytic leukemiaNeoplasmSarcomaChemotherapyMyelodysplastic SyndromesLeukaemiaImatinibCytotoxicSubtypeKnown as acute myeloidBlood and bone marrowRemissionNewly diagnosed acute myeloidMyeloblasticLeukemic cellsCellsManifestations of acute myeloidErythroidOncologyCancerTherapiesRefractoryLymphoma SocietyPrognosisRecurrentCancersMalignanciesBoneAdultsPatients with newly-diagnosedHematopoieticStem cell transplant2022PhaseProgressesPlateletsPositive regulatorIncidenceAbstractGVHDDiagnosisTypes of leukemia
Promyelocytic leukemia4
Neoplasms9
  • Acute myeloid leukemia (AML) and related neoplasms. (oncolink.org)
  • Therapy-related myeloid neoplasms. (oncolink.org)
  • Myeloid neoplasms with germline predisposition without a preexisting disorder or organ dysfunction. (oncolink.org)
  • Myeloid neoplasms with germline DDX41 mutation. (oncolink.org)
  • Myeloid neoplasms with germline predisposition and preexisting platelet disorders. (oncolink.org)
  • Myeloid neoplasms with germline predisposition and other organ dysfunction. (oncolink.org)
  • Certain myeloproliferative neoplasms may become acute myeloid leukemia (AML). (merck.com)
  • Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. (medscape.com)
  • Acute myeloid leukemia has a number of subtypes and precursor neoplasms that are distinguished from each other by morphology, immunophenotype, cytochemistry, and genetic abnormalities (see also The 2016 World Health Organization [WHO] Classification of myeloid neoplasms ) all of which have important implications for prognosis and treatment. (msdmanuals.com)
Myelocytic4
Myelomonocytic leukemia4
  • Juvenile myelomonocytic leukemia (JMML). (chkd.org)
  • Note=A chromosomal aberration involving PDGFRB is found in a form of chronic myelomonocytic leukemia (CMML). (abcam.com)
  • 5. Wu J, Fantasia JE, Kaplan R. Oral manifestations of acute myelomonocytic leukemia: a case report and review of the classification of leukemias. (bvsalud.org)
  • gingival hyperplasia complicating acute myelomonocytic leukemia. (bvsalud.org)
Neoplasm2
  • Midostaurin was also approved to treat adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN) and mast cell leukemia (MCL). (rxwiki.com)
  • Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by an acquired 9;22-chromosomal translocation in a hematopoietic stem cell (HSC) resulting in the expression of the BCR-ABL1 fusion protein. (haematologica.org)
Sarcoma4
  • Myeloid sarcoma. (oncolink.org)
  • Occasionally, AML cells can form a solid tumor called a myeloid sarcoma or chloroma that can develop anywhere in the body. (cancer.net)
  • AML affects the ocular system through direct infiltration of tissues, secondary to hematological abnormalities, or in the form of chloroma or myeloid sarcoma in the brain or orbit consequently leading to a variety of manifestations depending on the ocular tissue involved. (dovepress.com)
  • Myeloid sarcoma, also known as chloroma, granulocytic sarcoma or myeloblastoma is a type of extramedullary myeloid tumor. (dovepress.com)
Chemotherapy4
Myelodysplastic Syndromes1
  • Some persons with clonal hematopoiesis are at increased risk for the development of myeloid cancers such as acute myeloid leukemia or myelodysplastic syndromes, a risk that increases as the hematopoietic clone expands in size.16 Stopping this expansion may delay or avert leukemic progression, and therapeutic approaches to this end are being developed and tested. (cdc.gov)
Leukaemia4
  • Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. (nature.com)
  • Acute leukaemia presenting as oral ulceration to a dental emergency service. (bvsalud.org)
  • 7. Bergmann OJ, Philipsen HP, Ellegaard J. Isolated gingival relapse in acute myeloid leukaemia. (bvsalud.org)
  • There are many other signs of chronic myelogenous leukaemia. (psychokinesis.co.il)
Imatinib4
  • Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. (medscape.com)
  • Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses. (medscape.com)
  • Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. (medscape.com)
  • Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib. (medscape.com)
Cytotoxic2
  • Therapy related leukemia this is complication of treatment that can develop months to years or even decades after exposure to cytotoxic agents or radiotherapy or both. (standardofcare.com)
  • The risk of secondary leukemia is associated with the type of cytotoxic agents, cumulative dose, intensity of such agents and cumulative ionizing radiation doses. (standardofcare.com)
Subtype3
Known as acute myeloid1
Blood and bone marrow2
Remission2
  • Estimate rates of acute and chronic GvHD, infections, complete remission and neutrophil recovery. (survivornet.com)
  • Treatments for Chronic Myelogenous Leukemia will depend on your age and general health, but the goal is to have long-term remission. (psychokinesis.co.il)
Newly diagnosed acute myeloid1
  • The agency approved Rydapt ( midostaurin ) to treat newly diagnosed acute myeloid leukemia (AML). (rxwiki.com)
Myeloblastic1
Leukemic cells1
  • The biopsy specimen from the right maxillary sinus showed soft tissue infiltration with myeloid leukemic cells, consistent with a chloroma. (contemporarypediatrics.com)
Cells41
  • Bone marrow aspiration and biopsy will show if there are any leukemia cells. (medlineplus.gov)
  • Subtypes are based on specific changes in genes (mutations) and how the leukemia cells appear under the microscope. (medlineplus.gov)
  • Leukemia is an umbrella term for cancers affecting the blood-forming cells in the body. (medicalnewstoday.com)
  • It is different than other forms of leukemia because it has eight distinct subtypes, which develop from different types of cells. (medicalnewstoday.com)
  • Doctors use this treatment regimen to eliminate leukemia cells and bring blood counts back to normal. (medicalnewstoday.com)
  • In the accelerated phase, these leukemia cells grow quickly. (wikipedia.org)
  • Leukemia is cancer that starts in young (immature) blood cells. (chkd.org)
  • The leukemia cells grow in bone marrow and then go out into the blood. (chkd.org)
  • When a child has leukemia, the bone marrow makes abnormal blood cells that don't mature and don't work the way they should. (chkd.org)
  • This test can show if there are leukemia cells in the bone marrow. (chkd.org)
  • Approximately 40% of those affected with leukemia will have Acute Myeloid Leukemia (AML), a cancer of the BM and blood wherein blood cells are unable to develop or function normally, are overproduced at an immature stage of development and overtake any normal elements remaining in the BM and blood. (aiche.org)
  • chronic leukemias are composed of more mature cells. (curehunter.com)
  • Acute myelogenous leukemia (AML) is a blood cancer that affects white blood cells, red blood cells, and/or platelets. (oncolink.org)
  • A lumbar puncture (spinal tap) to see if there are any leukemia cells in your spinal fluid. (oncolink.org)
  • The treatment is designed to wipe out the abnormally functioning leukemia cells. (oncolink.org)
  • Leukemia is cancer of the white blood cells. (rxwiki.com)
  • In leukemia, the bone marrow produces abnormal white blood cells. (rxwiki.com)
  • Leukemia is a group of cancers that develop in the cells that produce blood cells. (healthline.com)
  • Acute myeloid leukemia (AML) starts in the bone marrow, the spongy tissue inside your bones that makes blood cells. (cancer.net)
  • AML progresses rapidly, with myeloid cells interfering with the production of normal white blood cells, red blood cells and platelets. (delveinsight.com)
  • Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells. (medscape.com)
  • Leukemia is a cancer that mostly affects white blood cells. (kidshealth.org)
  • With leukemia (loo-KEE-mee-uh), the bone marrow makes white blood cells that don't work. (kidshealth.org)
  • Acute myeloid leukemia (AML) happens when the body makes too many immature blood cells. (kidshealth.org)
  • These cells, called myeloid (MYE-uh-loyd) blasts, can't mature into normal white blood cells. (kidshealth.org)
  • Because their white blood cells can't fight infections, kids with leukemia are more likely to get viral or bacterial infections. (kidshealth.org)
  • Doctors use these to rule out other causes of symptoms, or look for a mass of leukemia cells in the chest that can affect breathing or blood circulation. (kidshealth.org)
  • Acute myeloid leukemia (AML) is a malignant disorder of the hematopoietic stem cells characterized by abnormal proliferation of myeloid blast cells in the bone marrow and blood, preventing them from further differentiating into the specialized cells of the bone marrow and thus causing pancytopenia. (dovepress.com)
  • To identify regulators of primitive chronic myeloid leukemia (CML) cells, we performed a high-content cytokine screen using primary CD34 + CD38 low chronic phase CML cells. (haematologica.org)
  • The disease progresses rapidly, affecting a group of white blood cells called myeloid cells, which normally develop into mature red blood cells, white blood cells and platelets. (iheart.com)
  • Regulatory T cells in acute myelogenous leukemia: Is it time for immunomodulation? (umn.edu)
  • The microenviroment of acute myelogenous leukemia (AML) is suppressive for immune effector cells. (umn.edu)
  • Dive into the research topics of 'Regulatory T cells in acute myelogenous leukemia: Is it time for immunomodulation? (umn.edu)
  • There are many different symptoms that are common with chronic myelogenous leukemia, which affects the blood cells and bone marrow. (psychokinesis.co.il)
  • AML, also known as acute myelogenous leukemia or acute non-lymphocytic leukemia, is a kind of leukemia that affects the blood cells. (databridgemarketresearch.com)
  • A mature blood cell from a myeloid stem cell is one of three types that are red blood cells, granulocytes, and platelets. (databridgemarketresearch.com)
  • In acute myeloid leukemia (AML), malignant transformation and uncontrolled proliferation of an abnormally differentiated, long-lived myeloid progenitor cell results in high circulating numbers of immature blood cells and replacement of normal marrow by malignant cells. (msdmanuals.com)
  • The major goals of my research are to identify how acute myeloid leukemia (AML) cells suppress the innate immune system and use this knowledge to develop new immunotherapies. (lu.se)
  • I will accomplish this by identifying and mechanistically characterize cell surface proteins that protect leukemia cells against the innate immune system. (lu.se)
  • To identify cell surface proteins on leukemia cells that inhibit Natural killer cells ( Aim 1a ) or macrophages ( Aim 1b ) using CRISPR screens. (lu.se)
  • To characterize the function and expression patterns of the identified cell surface proteins in acute myeloid leukemia cells from patients. (lu.se)
Manifestations of acute myeloid2
  • The purpose of this review is to present and evaluate the medical literature regarding the early ophthalmological manifestations of acute myeloid leukemia. (dovepress.com)
  • 11 The purpose of this review is to present and evaluate the medical literature on the early ophthalmological manifestations of acute myeloid leukemia, which physicians should be aware of for an earlier and more efficient diagnosis and treatment. (dovepress.com)
Erythroid1
Oncology1
Cancer10
Therapies3
  • My long-term goal is to improve patient outcomes by establishing therapies that prevent and/or delay evolution to acute leukemia. (lls.org)
  • I have expertise in novel therapies for acute myeloid leukemia, stem cell mobilization and homing, as well as stem cell transplantation. (rochester.edu)
  • From the article: 'In a real-world setting of new and emerging targeted therapies, a study found that patients with acute myeloid leukemia (AML) had unmet needs that hindered their ability to receive genomic testing and treatment options, especially for older patients with AML. (cdc.gov)
Refractory2
  • The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when given alone and in combination with ASTX727 in participants with relapsed/refractory (R/R) acute myeloid leukemia (AML). (mayo.edu)
  • The purpose of this open label study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of AZD1208 in patients with recurrent or refractory Acute Myelogenous Leukemia (AML). (astrazenecaclinicaltrials.com)
Lymphoma Society1
  • The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. (lls.org)
Prognosis1
  • Acute myeloid leukemia (AML) is a molecularly diverse malignancy with a poor prognosis whose largest subgroup is characterized by somatic mutations in NPM1 , which encodes nucleophosmin 1 . (nature.com)
Recurrent2
  • We also identified recurrent integrations in known and newly discovered leukemia genes including Nf1, Bach2, Dleu2 and Nup98 . (nature.com)
  • NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. (nature.com)
Cancers2
  • Despite decades of intensive effort, blood cancers like acute myelogenous leukemia (AML) remain largely incurable diseases. (lls.org)
  • in particular, patients with rare diseases like spinal muscular atrophy and certain cancers such as chronic myelogenous leukemia may now be prescribed personalized medicine treatments that simply didn't exist a couple of decades ago. (cdc.gov)
Malignancies1
  • My lab is focused on understanding the pathogenic interplay between oncogenic mutations, chronic inflammation and aberrant metabolism as a driver of the evolutionary processes that culminate in lethal myeloid malignancies. (lls.org)
Bone2
Adults4
Patients with newly-diagnosed1
  • Two hundred twenty-seven patients with newly diagnosed acute leukemia were enrolled on two sequential studies conducted from 1982 to 1991. (elsevierpure.com)
Hematopoietic1
  • This phase II trial studies how well total marrow and lymphoid irradiation works as a conditioning regimen before hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute leukemia. (survivornet.com)
Stem cell transplant1
20221
  • Data Bridge Market Research analyses that the Ecuador acute myeloid leukemia drugs market will grow at a CAGR of 4.5% during the forecast period of 2022 to 2029. (databridgemarketresearch.com)
Phase2
  • Accelerated phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which the disease is progressing. (wikipedia.org)
  • This is a multicenter, open-label, Phase 1/2a dose escalation and expansion study of orally administered emavusertib (CA-4948) monotherapy in adult patients with Acute Myelogenous Leukemia (AML) or high risk Myelodysplastic Syndrome (MDS). (rochester.edu)
Progresses2
Platelets1
  • When they don't have enough platelets (PLATE-lits), kids with leukemia may bruise easily, get nosebleeds, or bleed for a long time after even a minor cut. (kidshealth.org)
Positive regulator1
  • 7 In CML and acute myeloid leukemia (AML), we and others have shown that IL-1 is a positive regulator of LSC, and blocking IL-1 signaling inhibits the LSC. (haematologica.org)
Incidence1
  • From the above point we can conclude that the incidence of acute myeloid leukemia is increasing rapidly in Ecuador and Ecuador, as a result the market of acute myeloid leukemia drugs market is also increasing. (databridgemarketresearch.com)
Abstract1
  • abstract = "In order to analyse the clinical characteristics and outcome in acute myelogenous leukemia, 129 consecutive adult patients admitted to our hospital over a 10-year period, from August 1984 to July 1994, were studied. (fujita-hu.ac.jp)
GVHD1
  • Complications: including acute/chronic GVHD, infection and delayed engraftment. (survivornet.com)
Diagnosis2
  • There are 2 staging systems that are commonly used during diagnosis of acute myeloid leukemia (AML). (medscape.com)
  • Today, we're going to discuss pregnancy, family planning, and fertility for patients with a diagnosis of CML, which is not a topic generally mixed with leukemia very often. (medscape.com)
Types of leukemia4